ClinicalTrials.gov
public full text
Public Domain
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
breast-cancercervical-cancercholangiocarcinomacolorectal-cancerhead-and-neck-cancerhepatocellular-carcinoma-hccnon-small-cell-lung-cancerovarian-cancer
The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma#1031880
- 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR#992709
- Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.#869475
- Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT#863977
- PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning#1171866
Record · ID 881267
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive